3950 South Country Club Road
Suite 470 4th Floor
Tucson, AZ 85714
United States
520 365 3100
https://acceleratediagnostics.com
Sector(s):Â Healthcare
Industry:Â Medical Devices
Full Time Employees:Â 220
Name | Title | Pay | Exercised | Year Born |
---|---|---|---|---|
Mr. Jack Phillips | CEO, Pres & Director | 703.01k | N/A | 1966 |
Mr. Steve Reichling | Chief Financial Officer | 340k | N/A | 1978 |
Mr. Ron Price | Chief Commercial Officer of Americas | 240k | N/A | 1964 |
Laura Pierson | Investor Relations Officer | N/A | N/A | N/A |
Mr. Michael Bridge | Sr. VP, Gen. Counsel & Sec. | N/A | N/A | N/A |
Ms. Gretchen Strohminger | Sr. VP and Head of HR & Culture | N/A | N/A | N/A |
Mr. Cherif Bousselham | Sr. VP & Head of Sales - EMEA | N/A | N/A | N/A |
Ms. Laura Costa | Sr. VP & Head of Global Customer Support | N/A | N/A | N/A |
Mr. John Meduri | Chief Strategy Officer | N/A | N/A | N/A |
Dr. Lawrence Mertz | Sr. VP and Head of R&D | N/A | N/A | N/A |
Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. The company offers Accelerate Pheno system, an in vitro diagnostic platform for the identification and antibiotic susceptibility testing of pathogens associated with serious or health care-associated infections, including gram-positive and gram-negative organisms. It also provides the Accelerate PhenoTest, a test kit for the system, which provides identify and antibiotic susceptibility testing results for patients suspected of bacteremia or fungemia, both life-threatening conditions with high morbidity and mortality risk. The company was formerly known as Accelr8 Technology Corporation and changed its name to Accelerate Diagnostics, Inc. in December 2012. Accelerate Diagnostics, Inc. was incorporated in 1982 and is headquartered in Tucson, Arizona.
Accelerate Diagnostics, Inc.’s ISS Governance QualityScore as of May 1, 2022 is 7. The pillar scores are Audit: 7; Board: 6; Shareholder Rights: 2; Compensation: 10.